M85.022
Fibrous dysplasia (monostotic), left upper arm
Clinical Classification Guidelines
Medical Intelligence & Overview
Fibrous dysplasia is a rare bone disorder where normal bone is replaced with fibrous tissue, leading to weak bones, deformities, and fractures. When it affects a single bone, it is called monostotic fibrous dysplasia. Specifically, ICD-10 Code M85.022 refers to this condition located in the left upper arm, involving the humerus. Though the condition can be present at birth or develop during childhood or adolescence, symptoms and severity vary among individuals. Recognizing and understanding this condition is essential for managing its effects and preventing complications.
Causes & Symptoms
Clinical Causes: Genetic mutations: The condition often results from a mutation in the GNAS gene, which influences bone development and growth. Developmental factors: Fibrous dysplasia occurs early in life, during bone development, but specific causes remain largely unknown. No clear environmental link: Unlike some bone diseases, environmental factors do not appear to directly cause fibrous dysplasia.
Key Symptoms: Bone deformity: Noticeable abnormal shape or curve in the affected limb. Bone pain: Discomfort or tenderness in the involved arm, especially after activity. Swelling or a lump: Visible swelling or palpable mass over the affected area. Fractures: Increased susceptibility to bone fractures due to weakened bone structure. Limited mobility: Reduced range of motion or difficulty using the affected limb.
Diagnostic & Treatment
Diagnosis Path: Diagnosing monostotic fibrous dysplasia typically involves a combination of clinical evaluation and imaging studies. X-rays may reveal characteristic changes such as a 'ground-glass' appearance in the affected bone. Magnetic resonance imaging (MRI) and computed tomography (CT) scans can provide detailed insights into the extent of the lesion. A biopsy may be performed to confirm the diagnosis by examining bone tissue under a microscope, identifying fibrous tissue replacing normal bone. Blood tests are generally not diagnostic but may be used to rule out other conditions or assess overall health.
Treatment Protocols: While there is no cure for fibrous dysplasia, various treatments aim to manage symptoms, prevent fractures, and correct deformities. Approaches include: - Pain management: Use of pain relievers to alleviate discomfort. - Monitoring: Regular imaging to track lesion progression and detect complications. - Surgical intervention: Procedures such as curettage (removal of diseased tissue), bone grafting, or corrective osteotomies to fix deformities or stabilize the bone. - Bisphosphonates: Medications that can reduce bone pain and potentially stabilize bone turnover, although evidence varies. - Activity modification: Avoiding excessive strain or trauma to the affected limb. The specific treatment plan depends on the severity of symptoms, extent of bone involvement, and impact on daily activities. Management often involves a multidisciplinary team including orthopedists, radiologists, and physical therapists.
Clinical Advice & FAQs
Billing Guidance
Is M85.022 a billable ICD-10 code?
Yes, M85.022 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M85.022?
Clinical documentation must specify the nature of Fibrous dysplasia (monostotic), left upper arm and any associated comorbidities for accurate reporting.
Cite this Clinical Reference